Viramune Expanded Access Program begins.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015507:Drugs, Investigational; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D017387:Investigational New Drug Application; D008297:Male; D019829:Nevirapine; D011725:Pyridines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine